Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Grassegger

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical and Experimental Dermatology|November 20, 2004
Significance of the cytokine interferon gamma in clinical dermatologyA Grassegger, R Höpfl
Der Anaesthesist|November 13, 2001
[Is the use of tumescence anesthesia in general anesthesia contraindicated]?Anaesthesist. 2001 May;50(5):363-4]A Grassegger, R Häussler
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 7, 2001
Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective studyA Grassegger, P Fritsch, N Reider
European Journal of Pharmacology|May 11, 1989
(+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptorsR Boer, A Grassegger, C Schudt, et al.
The British Journal of Dermatology|February 1, 1994
Buschke-Loewenstein tumour infiltrating pelvic organsA Grassegger, R Höpfl, H Hussl, et al.
The British Journal of Dermatology|November 1, 1996
Immunoglobulin A (IgA) deposits in lesional skin of a patient with blepharochalasisA Grassegger, N Romani, P Fritsch, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|February 1, 1991
[Urticarial vasculitis as a symptom of Muckle-Wells syndrome?]A Grassegger, R Greil, J Feichtinger, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1989
[3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domainA Grassegger, J Striessnig, M Weiler, et al.
The American Journal of Cardiology|November 7, 1989
Hydrophobic calcium channel ligands: methodical problems and their solutionI Graziadei, G Zernig, A Grassegger, et al.
Experimental Dermatology|May 8, 2002
Expression of the C-C chemokine MIP-3 alpha/CCL20 in human epidermis with impaired permeability barrier functionM Schmuth, S Neyer, C Rainer, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical and Experimental Dermatology|November 20, 2004
Significance of the cytokine interferon gamma in clinical dermatologyA Grassegger, R Höpfl
Der Anaesthesist|November 13, 2001
[Is the use of tumescence anesthesia in general anesthesia contraindicated]?Anaesthesist. 2001 May;50(5):363-4]A Grassegger, R Häussler
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 7, 2001
Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective studyA Grassegger, P Fritsch, N Reider
European Journal of Pharmacology|May 11, 1989
(+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptorsR Boer, A Grassegger, C Schudt, et al.
The British Journal of Dermatology|February 1, 1994
Buschke-Loewenstein tumour infiltrating pelvic organsA Grassegger, R Höpfl, H Hussl, et al.
The British Journal of Dermatology|November 1, 1996
Immunoglobulin A (IgA) deposits in lesional skin of a patient with blepharochalasisA Grassegger, N Romani, P Fritsch, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|February 1, 1991
[Urticarial vasculitis as a symptom of Muckle-Wells syndrome?]A Grassegger, R Greil, J Feichtinger, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1989
[3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domainA Grassegger, J Striessnig, M Weiler, et al.
The American Journal of Cardiology|November 7, 1989
Hydrophobic calcium channel ligands: methodical problems and their solutionI Graziadei, G Zernig, A Grassegger, et al.
Experimental Dermatology|May 8, 2002
Expression of the C-C chemokine MIP-3 alpha/CCL20 in human epidermis with impaired permeability barrier functionM Schmuth, S Neyer, C Rainer, et al.
Pageof 2